We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for risdiplam (Roche Products Pty Limited)
Active ingredients
risdiplam
Sponsor
Date of review outcome
Lapse date
Type
Priority review
Indication
For the treatment of 5q Spinal Muscular Atrophy (SMA)
Therapeutic area
Neurology